Company news
Benitec Biopharma Inc. news in 2026
Benitec Biopharma Inc.'s news releases, calls and decks from 2026, newest first.
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301
October 28, 2026
Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
October 5, 2026
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
September 14, 2026
Unleash Your Ultimate Kaiju! Godziburst and Godzilla Scramble Figures Available for Pre-Order Starting June 25
June 25, 2026
Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update
May 13, 2026
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting
April 28, 2026
Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development fo...
March 9, 2026
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
March 8, 2026
Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference
February 22, 2026
Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update
February 12, 2026
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response
January 11, 2026
Decks in 2026
- American Society of Cell & Gene Therapy 2026
Conference · 20 slides · May 15, 2026
- Investor Presentation (January 2026)
Investor deck · 43 slides · January 2026